C86.01
Extranodal NK/T-cell lymphoma, nasal type, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Extranodal NK/T-cell lymphoma, nasal type, is a rare form of lymphoma that primarily affects the nasal area and surrounding structures. When a person is described as being 'in remission' for this condition, it means that, after treatment, the signs and symptoms of the disease have significantly decreased or disappeared. This state indicates that the lymphoma is not currently active, although ongoing monitoring is often necessary to detect any potential recurrence. The ICD-10 code C86.01 is used by medical professionals to classify this specific condition in medical records and billing.
Causes & Symptoms
Clinical Causes: The exact cause of extranodal NK/T-cell lymphoma is unknown. Infection with the Epstein-Barr virus (EBV) has been associated with the development of this lymphoma. Certain genetic factors may increase susceptibility, though specific genetic causes are not well understood. Environmental factors, such as exposure to certain chemicals, may play a role, but evidence is limited.
Key Symptoms: Nasal congestion or blockage Nasal bleeding (epistaxis) Swelling or mass in the nasal or facial area Persistent sore or ulcer in the nasal cavity Facial pain or swelling Unexplained weight loss Fever and night sweats Fatigue Enlargement of lymph nodes in adjacent regions
Diagnostic & Treatment
Diagnosis Path: Nasal endoscopy to visualize the nasal cavity and obtain tissue samples. Imaging tests such as CT scans or PET scans to determine the extent of the disease. Histopathological examination of biopsy samples, including immunophenotyping, to confirm the lymphoma type. Blood tests to assess overall health and detect any systemic involvement.
Treatment Protocols: Chemotherapy to target and destroy cancerous cells. Radiation therapy to eliminate lymphoma in localized areas, especially nasal and adjacent tissues. Targeted therapies or immunotherapies may be considered in specific cases. Supportive care to manage symptoms and improve quality of life during and after treatment.
Clinical Advice & FAQs
Billing Guidance
Is C86.01 a billable ICD-10 code?
Yes, C86.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C86.01?
Clinical documentation must specify the nature of Extranodal NK/T-cell lymphoma, nasal type, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference